1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor-kappaB	factor-kappaB	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	monocytes	monocyte	_	_	_	_	_	_	_
7	stimulated	stimulate	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	inhibited	inhibit	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	fibroblast	fibroblast	_	_	_	_	_	_	_
14	conditioned	conditioned	_	_	_	_	_	_	_
15	medium	medium	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	exogenous	exogenous	_	_	_	_	_	_	_
18	PGE2	pge2	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	nuclear	nuclear	_	_	_	_	_	_	_
3	factor	factor	_	_	_	_	_	_	_
4	kappaB	kappaB	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	thought	think	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	crucially	crucially	_	_	_	_	_	_	_
13	involved	involve	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	gene	gene	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	several	several	_	_	_	_	_	_	_
20	cytokines	cytokine	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	including	include	_	_	_	_	_	_	_
23	tumor	tumor	_	_	_	_	_	_	_
24	necrosis	necrosis	_	_	_	_	_	_	_
25	factor	factor	_	_	_	_	_	_	_
26	alpha	alpha	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	TNF	TNF	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Previously	previously	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	showed	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	fibroblast	fibroblast	_	_	_	_	_	_	_
7	conditioned	conditioned	_	_	_	_	_	_	_
8	medium	medium	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	FCM	FCM	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	able	able	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	inhibit	inhibit	_	_	_	_	_	_	_
16	both	both	_	_	_	_	_	_	_
17	TNF	TNF	_	_	_	_	_	_	_
18	mRNA	mrna	_	_	_	_	_	_	_
19	accumulation	accumulation	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	release	release	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	peripheral	peripheral	_	_	_	_	_	_	_
25	blood-derived	blood-derived	_	_	_	_	_	_	_
26	human	human	_	_	_	_	_	_	_
27	monocytes	monocyte	_	_	_	_	_	_	_
28	(	(	_	_	_	_	_	_	_
29	PBM	PBM	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	stimulated	stimulate	_	_	_	_	_	_	_
32	with	with	_	_	_	_	_	_	_
33	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	LPS	LPS	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	have	have	_	_	_	_	_	_	_
6	investigated	investigate	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	effect	effect	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	FCM	FCM	_	_	_	_	_	_	_
11	on	on	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	LPS-induced	lps-induced	_	_	_	_	_	_	_
14	DNA-binding	dna-binding	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	means	mean	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	electrophoretic	electrophoretic	_	_	_	_	_	_	_
23	shift	shift	_	_	_	_	_	_	_
24	assay	assay	_	_	_	_	_	_	_
25	(	(	_	_	_	_	_	_	_
26	EMSA	EMSA	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	provide	provide	_	_	_	_	_	_	_
3	evidence	evidence	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	FCM	FCM	_	_	_	_	_	_	_
6	strongly	strongly	_	_	_	_	_	_	_
7	inhibits	inhibit	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	LPS-induced	lps-induced	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	PBM	PBM	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	show	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	exogenous	exogenous	_	_	_	_	_	_	_
7	PGE2	pge2	_	_	_	_	_	_	_
8	mimics	mimic	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	inhibitory	inhibitory	_	_	_	_	_	_	_
12	effect	effect	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	FCM	FCM	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	hand	hand	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	FCM	FCM	_	_	_	_	_	_	_
7	produced	produce	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	presence	presence	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	indomethacin	indomethacin	_	_	_	_	_	_	_
13	does	do	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	inhibit	inhibit	_	_	_	_	_	_	_
16	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	LPS	LPS	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	lend	lend	_	_	_	_	_	_	_
4	further	further	_	_	_	_	_	_	_
5	support	support	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	hypothesis	hypothesis	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	inflammatory	inflammatory	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	immune	immune	_	_	_	_	_	_	_
13	responses	response	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	monocytes/macrophages	monocytes/macrophage	_	_	_	_	_	_	_
16	may	may	_	_	_	_	_	_	_
17	be	be	_	_	_	_	_	_	_
18	modulated	modulate	_	_	_	_	_	_	_
19	at	at	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	molecular	molecular	_	_	_	_	_	_	_
22	level	level	_	_	_	_	_	_	_
23	by	by	_	_	_	_	_	_	_
24	signals	signal	_	_	_	_	_	_	_
25	originating	originate	_	_	_	_	_	_	_
26	from	from	_	_	_	_	_	_	_
27	tissue	tissue	_	_	_	_	_	_	_
28	structural	structural	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	such	such	_	_	_	_	_	_	_
31	as	as	_	_	_	_	_	_	_
32	fibroblasts	fibroblast	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

